Evidence map›Paper›PMID 36755499›Full record

ArticleRevista espanola de salud publica2023

[The experience of community pharmacy in SARS-CoV-2 antigen detection tests programs.]

Carlos Fernández Moriano, Tamara Peiró Zorrilla, Iván A Espada Ibáñez, Paula Mateos Sánchez, Tamara Dorado Romero, Antonio Blanes Jiménez

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Revista espanola de salud publica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Carlos Fernández MorianoConsejo General de Colegios Farmacéuticos de España. Madrid. España.
Tamara Peiró ZorrillaConsejo General de Colegios Farmacéuticos de España. Madrid. España.
Iván A Espada IbáñezConsejo General de Colegios Farmacéuticos de España. Madrid. España.
Paula Mateos SánchezConsejo General de Colegios Farmacéuticos de España. Madrid. España.
Tamara Dorado RomeroConsejo General de Colegios Farmacéuticos de España. Madrid. España.
Antonio Blanes JiménezConsejo General de Colegios Farmacéuticos de España. Madrid. España.
Laboratorios Farmaceúticos Rovi (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 infection was an unprecedented pandemic with unprecedented global health and socio-economic impact. More than 13 million cases had been confirmed in Spain by August 2022, and diagnostic testing to detect cases of infection in the country has helped to partially mitigate the spread of the virus. In 2021, the first self-testing antigen tests were marketed for dispensing in community pharmacies, and over-the-counter dispensing was allowed from July of that year. The network of community pharmacies played a key role, not only in the informed dispensing of these tests, but also in actively participating in the performance, supervision and reporting of results to the health authorities, and even in the issuing of digital certificates. A compilation has been made of all the available data on the subject, with a deadline of 13 February 2022, which is considered to be the end of the sixth wave of the epidemic in Spain. The results of the action taken by community pharmacies in twelve Autonomous Communities, which somehow participated in these initiatives by carrying out or supervising a total of 1,043,800 tests, from which 109,570 positive cases (10.5% of the total) were detected and reported to the National Health System, are presented in this article. Although the results are provisional, because many of the programmes are still ongoing, they are a clear demonstration of the potential that community pharmacies can play in Public Health work.

Indexed as

COVID-19PharmaciesHumansLongitudinal StudiesSARS-CoV-2SpainAntigen detection testCommunity pharmacyCOVID-19PharmacistsSARS-CoV-2Self-diagnosis testSpain

Identifiers

PMID36755499
PMCPMC10540908
OpenAlexW4319655938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.